Trials / Terminated
TerminatedNCT04610827
Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder
Optimum Frequency and Timing of Oral Iron Administration for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 2 Years – 10 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to see if the level of serum ferritin differs based on how often oral iron (in the form of ferrous sulfate) is given to children with restless leg syndrome/periodic limb movement disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferrous sulfate | Guideline-recommended 3 mg/kg/day dosing |
Timeline
- Start date
- 2020-11-16
- Primary completion
- 2021-06-29
- Completion
- 2021-06-29
- First posted
- 2020-11-02
- Last updated
- 2024-05-22
- Results posted
- 2024-05-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04610827. Inclusion in this directory is not an endorsement.